- Home
- FDSB vs MAIA Comparison
FDSB vs MAIA Comparison
Compare FDSB & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDSB
- MAIA
- Stock Information
- Founded
- FDSB 1926
- MAIA 2018
- Country
- FDSB United States
- MAIA United States
- Employees
- FDSB N/A
- MAIA N/A
- Industry
- FDSB
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- FDSB
- MAIA Health Care
- Exchange
- FDSB NYSE
- MAIA Nasdaq
- Market Cap
- FDSB 69.2M
- MAIA 56.3M
- IPO Year
- FDSB N/A
- MAIA 2022
- Fundamental
- Price
- FDSB $13.18
- MAIA $1.70
- Analyst Decision
- FDSB
- MAIA
- Analyst Count
- FDSB 0
- MAIA 0
- Target Price
- FDSB N/A
- MAIA N/A
- AVG Volume (30 Days)
- FDSB 23.0K
- MAIA 468.1K
- Earning Date
- FDSB 08-15-2025
- MAIA 08-08-2025
- Dividend Yield
- FDSB N/A
- MAIA N/A
- EPS Growth
- FDSB N/A
- MAIA N/A
- EPS
- FDSB 0.02
- MAIA N/A
- Revenue
- FDSB $12,612,000.00
- MAIA N/A
- Revenue This Year
- FDSB N/A
- MAIA N/A
- Revenue Next Year
- FDSB N/A
- MAIA N/A
- P/E Ratio
- FDSB $555.11
- MAIA N/A
- Revenue Growth
- FDSB 40.41
- MAIA N/A
- 52 Week Low
- FDSB $9.85
- MAIA $1.40
- 52 Week High
- FDSB $14.50
- MAIA $3.74
- Technical
- Relative Strength Index (RSI)
- FDSB N/A
- MAIA 44.78
- Support Level
- FDSB N/A
- MAIA $1.64
- Resistance Level
- FDSB N/A
- MAIA $1.74
- Average True Range (ATR)
- FDSB 0.00
- MAIA 0.09
- MACD
- FDSB 0.00
- MAIA -0.01
- Stochastic Oscillator
- FDSB 0.00
- MAIA 11.76
About FDSB FIFTH DISTRICT BANCORP INC.
Fifth District Bancorp inc is a holding company of Fifth District. Fifth District portfolio consists primarily of fixed-rate one- to four-family residential mortgage loans also originate construction loans, home equity loans, home equity lines of credit, land loans, and share loans (loans secured by deposit accounts at Fifth District) and purchase commercial business loans. The company offer a variety of deposit accounts including checking accounts, money market accounts, and certificates of deposit. In addition, it offers electronic banking services including mobile banking, on-line banking, telephone banking, bill pay, and electronic funds transfer via SmartPay.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.